French company Carmat announces first implant of its artificial heart in a woman

[September 21, 2021]  PARIS (Reuters) - French artificial heartmaker Carmat announced on Tuesday that it had carried out the first implant of its Aeson artificial heart in a woman.

The company said the procedure had been performed at the UofL Health - Jewish Hospital by University of Louisville physicians in the United States.

"This third implant in the U.S. was a landmark event not only because it allowed us to finalize the enrollment of the first cohort of patients of the EFS (early feasibility study), but very importantly because it is the first time ever that our device has helped a woman suffering from heart failure," Carmat CEO Stephane Piat said in a statement.

(Reporting by Matthieu Protard; Editing by Sudip Kar-Gupta)

[© 2021 Thomson Reuters. All rights reserved.]

Copyright 2021 Reuters. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.  Thompson Reuters is solely responsible for this content